Understanding how immune cells interact after traumatic brain injury
The role of monocyte and microglia interaction in the evolution of traumatic brain injury-induced neurodegeneration
This study is looking at how two types of immune cells in the brain interact after a traumatic brain injury, with the goal of finding ways to help people recover better from their injuries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10674026 on NIH RePORTER |
What this research studies
This research investigates the complex interactions between monocytes and microglia, two types of immune cells, following a traumatic brain injury (TBI). By using a specialized mouse model, the study aims to uncover the molecular mechanisms that drive these interactions and how they contribute to the progression of neurological impairment after TBI. The research focuses on understanding how these immune responses can affect recovery and long-term outcomes for individuals who have experienced TBI. Insights gained from this research could lead to the development of targeted therapies to improve recovery for TBI patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have sustained a traumatic brain injury, particularly those experiencing significant neurological impairment.
Not a fit: Patients with mild or no symptoms following a traumatic brain injury may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that enhance recovery and reduce long-term neurological damage in patients with traumatic brain injury.
How similar studies have performed: Previous research has shown promising results in understanding immune responses in brain injuries, suggesting that this approach could yield valuable insights.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Schwulst, Steven J — Northwestern University at Chicago
- Study coordinator: Schwulst, Steven J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.